Verdiva Bio Seed

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for obesity and cardiometabolic diseases. Their pipeline includes both oral and injectable therapies designed to enhance efficacy, improve patient convenience, and achieve better long-term outcomes, with a particular emphasis on patient-friendly options like once-weekly dosing. The company leverages advancements in gut-brain biology to create novel medicines addressing significant unmet medical needs globally.